Quick Dispatch:
Your soul trial oral semaglutide cardiovascular outcomes results New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your soul trial oral semaglutide cardiovascular outcomes results New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss ships.
Need Help?
Questions about soul trial oral semaglutide cardiovascular outcomes results New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for soul trial oral semaglutide cardiovascular outcomes results New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss in your area.
Results of SOUL Trial with Oral Semaglutide
24.41
PDF) Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial
26.12
Full article: Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients
22.38
Unveiling Cardiovascular Benefits of Oral Semaglutide in High-Risk Type 2 Diabetes: Findings from the SOUL Trial
24.44
NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial. Read the full trial results at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM
25.29
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
22.67
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
22.42
